The evolving biology of cross-presentation.

Area of Science:

• Immunology
• Cellular Biology

Background:

• Cross-priming, now known as cross-presentation, was initially observed in cytotoxic T lymphocyte (CTL) responses against minor histocompatibility antigens.
• Early studies suggested exogenous antigens are acquired by host antigen presenting cells (APCs) to prime CTLs.
• Understanding T cell receptor recognition of processed peptides presented by MHC molecules refined the concept of cross-presentation.

Purpose of the Study:

• To investigate the in vivo mechanisms and pathways of cross-presentation.
• To validate in vitro findings regarding cross-presentation pathways and gene candidates in an in vivo context.
• To determine the relative contributions of different cross-presentation pathways across various antigens and immunological settings.

Main Methods:

• Utilizing in vivo studies focusing on type 1 dendritic cells as key APCs.
• Validating putative pathways and gene candidates identified from in vitro studies.
• Evaluating CTL responses to diverse antigen forms in different physiological settings.

Main Results:

• In vitro models may differ mechanistically from in vivo APCs.
• Type 1 dendritic cells are a focus for in vivo cross-presentation studies.
• Cross-presentation involves diverse pathways dependent on cell type, antigen form, and physiological context.

Conclusions:

• Cross-presentation mechanisms are complex and context-dependent.
• Further in vivo evaluation is needed to fully understand cross-presentation pathways.
• The findings highlight the need to consider diverse cellular and physiological settings when studying cross-presentation.